Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft leitender kardiologischer Krankenhauärzte (ALKK) - Neuhaus, K-L; Essen, RV; Tebbe, U; Jessel, A; Heinrichs, H; Mäurer, W; Döring, W; Harmjanz, D; Kötter, V; Kalhammer, E; Simon, H; Horacek, T (Circulation, 1994)